Paul J Tuite

M.D.

1990 …2021
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research interests

  • mri

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 10 Similar Profiles
Parkinson Disease Medicine & Life Sciences
Progressive Supranuclear Palsy Medicine & Life Sciences
Magnetic Resonance Imaging Medicine & Life Sciences
Placebos Medicine & Life Sciences
Tremor Medicine & Life Sciences
Parkinsonian Disorders Medicine & Life Sciences
Brain Medicine & Life Sciences
Movement Disorders Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1998 2021

Research Output 1990 2019

1 Citation (Scopus)

McLeod syndrome: Five new pedigrees with novel mutations

Weaver, J., Sarva, H., Barone, D., Bobker, S., Bushara, K., Hiller, A., Ishii, M., Jankovic, J., Lakhani, S., Niotis, K., Scharre, D. W., Tuite, P. J., Stutz, A. M., Westhoff, C. M. & Walker, R. H., Jul 1 2019, In : Parkinsonism and Related Disorders. 64, p. 293-299 7 p.

Research output: Contribution to journalArticle

Pedigree
Mutation
Tics
Obstructive Sleep Apnea
Creatine Kinase

Motor phenotype classification in moderate to advanced PD in BioFIND study

Luo, L., Andrews, H., Alcalay, R. N., Poyraz, F. C., Boehme, A. K., Goldman, J. G., Xie, T., Tuite, P. J., Henchcliffe, C., Hogarth, P., Amara, A. W., Frank, S., Sutherland, M., Kopil, C., Naito, A. & Kang, U. J., Jan 1 2019, In : Parkinsonism and Related Disorders.

Research output: Contribution to journalArticle

Tremor
Phenotype
Gait
Dopamine Agents
Disease Progression
4 Citations (Scopus)

Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trial

Boxer, A. L., Qureshi, I., Ahlijanian, M., Grundman, M., Golbe, L. I., Litvan, I., Honig, L. S., Tuite, P. J., McFarland, N. R., O'Suilleabhain, P., Xie, T., Tirucherai, G. S., Bechtold, C., Bordelon, Y., Geldmacher, D. S., Grossman, M., Isaacson, S., Zesiewicz, T., Olsson, T., Muralidharan, K. K. & 4 others, Graham, D. L., O'Gorman, J., Haeberlein, S. B. & Dam, T., Jun 1 2019, In : The Lancet Neurology. 18, 6, p. 549-558 10 p.

Research output: Contribution to journalArticle

Progressive Supranuclear Palsy
Monoclonal Antibodies
Placebos
Safety
Urinary Tract Infections
1 Citation (Scopus)

Severity dependent distribution of impairments in PSP and CBS: Interactive visualizations

The AL-108-231 Study Group, The PROPSPERA investigators, 4RNTI-1authors & Tau Restoration on PSP (TAUROS) Investigators, Mar 1 2019, In : Parkinsonism and Related Disorders. 60, p. 138-145 8 p.

Research output: Contribution to journalArticle

Progressive Supranuclear Palsy
Clinical Trials
Extremities
Tauopathies
Therapeutic Uses
23 Citations (Scopus)

Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease Features

The Fox Investigation of New Biomarker Discovery, Feb 1 2018, In : Movement Disorders. 33, 2, p. 282-288 7 p.

Research output: Contribution to journalArticle

alpha-Synuclein
Saliva
Parkinson Disease
Cerebrospinal Fluid
Biomarkers